Navigation Links
Rising Incidence of Chronic Diseases in Children Drives the Pediatric Drugs and Vaccines Market, According to an Upcoming Report by Global Industry Analysts, Inc.
Date:7/21/2014

San Jose, California (PRWEB) July 21, 2014

Follow us on LinkedIn – GIA is pleased to announce the launch of a major research program analysing the trends impacting the market for “Pediatric Drugs and Vaccines”. Invited to participate in this comprehensive grassroots level global research initiative are senior industry executives, domain experts, technologists and market strategists. The new report to be issued shortly will offer accurate assessment of global market developments including major technologies, trends and challenges, together with descriptive, exploratory, and quantitative analysis of major product and geographic market segments. For details about participation in this primary research program to include your inputs prior to the publication, please click here.

Rise in chronic health conditions in children represents a major factor fuelling demand for pediatric drugs and vaccines. Poor dietary habits, sedentary lifestyles, and lack of exercise are resulting in increased prevalence of obesity, asthma, diabetes, behavioural and learning problems in children. Huge unmet medical needs in this market juxtaposed with saturating market opportunities in geriatric pharmaceuticals, is resulting in a large number of pharmaceutical companies shifting focus to pediatric drug development. Federal level recognition and acceptance of distinct therapeutic needs for pediatric patients is playing an instrumental role in encouraging pediatric drug development programs. Additionally, in an attempt to encourage manufacturers to perform clinical trials for the pediatric population, the FDA and EMA are adopting new regulations and policies. Developments in preclinical safety assessment, better understanding of pharmacological principles in pediatric drug development, and stringent formulation, chemistry, and manufacturing controls, will benefit the development of successful clinical therapeutics for this vulnerable patient population. Future growth in the market will come from pediatric vaccines, hormone therapy drugs, respiratory & allergy drugs, CNS drugs, and anti-infective drugs. Further, sales of other drugs including anti-obesity medicines are expected to grow, following their approval for pediatric use.

The upcoming report will offer coverage on major companies including Abbott Laboratories, GlaxoSmithKline Plc., Merck & Co. Inc., Novartis AG, Pfizer Inc., and Sanofi, among others.

In addition, the study will also provide:

  • Valuable market based intelligence on new emerging trends, growth drivers, issues and challenges.
  • Current coverage on company information and latest news and events including strategic corporate developments, and product innovations
  • Fresh research perspectives, statistical findings, analyst analysis, and commentaries
  • Accurate market estimates, projections, and forecasts across therapeutic segments (Pediatric Vaccines, Pediatric Hormones, Allergy &Respiratory Drugs, Anti-infective Drugs, CNS Drugs and Other) and major geographic markets (the United States, Europe, Asia-Pacific, Latin America, and Rest of World).

About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a leading publisher of off-the-shelf market research. Founded in 1987, the company currently employs over 800 people worldwide. Annually, GIA publishes 1500+ full-scale research reports and analyzes 40,000+ market and technology trends while monitoring more than 126,000 Companies worldwide. Serving over 9500 clients in 27 countries, GIA is recognized today, as one of the world's largest and reputed market research firms.

Global Industry Analysts, Inc.
Telephone: 408-528-9966
Fax: 408-528-9977
Email: press(at)StrategyR(dot)com
Web Site: http://www.StrategyR.com/

###

Read the full story at http://www.prweb.com/releases/pediatric_drugs_market/pediatric_vaccines/prweb12032702.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. LSUHSC research finds HPV-related head & neck cancers rising, highest in middle-aged white men
2. Surgery Rates Rising for Non-Melanoma Skin Cancer: Study
3. Catastrophic Head Injuries to High School Football Players Rising
4. Surprising results for use of dialysis for kidney failure in developing world
5. Rising Obesity Rates Might Mean More Rheumatoid Arthritis
6. Life-saving primary PCI rising in Stent for Life countries
7. NYC Doc Announces 3 Surprising Ways to Beat Seasonal Allergies
8. Discount Supermarkets Tied to Rising Obesity Rates
9. Rising Solar Engineering and Design Firm Enters 1.7 MW's in Connecticut ZREC Auction and Positions for Future Growth
10. Spending on childrens health rising faster than adults over past 4 years, says report
11. Generation X is surprisingly unconcerned about climate change
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... ... December 08, 2016 , ... The ... beginning January 1, 2017. The name change aligns the entire company with ... improving health care quality. , “We are very proud of the achievements associated ...
(Date:12/8/2016)... ... December 08, 2016 , ... The Florida Hospital Tampa ... Hyperbaric Medical Society (UHMS), the leading authority in hyperbaric medicine. This accreditation identifies ... few hospitals and facilities have earned this distinction. This is the second time ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... (WCRI) officially opened registration today for its 33rd Annual Issues & Research ... . , The theme of the conference is “Persistent Challenges and New Opportunities: ...
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... ... Donuts Franchising Company LLC, announced the first national #QuackGivesBack campaign which supported ... , “This was our first franchise-wide Quack Gives Back initiative, and ...
(Date:12/8/2016)... ... December 08, 2016 , ... ZyDoc , a New ... Conventional Data Capture Methods for Input to Electronic Health Records: A Comparative Usability ... the comparative usability study demonstrate that a dictation-based method (“NLP Entry”) using ZyDoc’s ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... IRIDEX Corporation (NASDAQ: IRIX ) today ... common stock, $0.01 par value (the "Offering" with such shares ... final terms of the Offering will depend on market and ... be no assurance as to whether or when the Offering ... net proceeds it will receive from this offering for working ...
(Date:12/8/2016)... LONDON , Dec. 8, 2016 Australia ... GlobalData,s new report, "Australia Ophthalmic Lasers Market Outlook to ... Lasers market. The report provides value, in millions of ... within market segements - Excimer Lasers, Femtosecond Lasers and ... and distribution shares data for each of these market ...
(Date:12/8/2016)... , Dec. 8, 2016 Australia ... Summary GlobalData,s new report, "Australia Glaucoma Surgery ... data on the Australia Glaucoma Surgery Devices market. ... dollars, volume (in units) and average prices (USD) ... The report also provides company shares and distribution ...
Breaking Medicine Technology: